1. A therapeutic composition comprising a C-type natriuretic peptide (CNP) or a B-type natriuretic peptide (BNP) for treating dermatitis with an immune response to at least one allergen selected from house dust, ticks, cedar pollen, and hedgehog pollen from the national team, pollen of ragweed, egg white and egg yolk, atopic dermatitis, eczema, dermatitis, which leads to steroid dermatitis, steroid-resistant dermatitis, erythroderma, post-exematous erythroderma, rosacea or any of the above types of dermatitis, to which e takrolimus.2 applicable. The therapeutic composition of claim 1, wherein the C-type natriuretic peptide (CNP) or the B-type natriuretic peptide (BNP) is a hybrid peptide of CNP and BNP that forms a ring structure via an intramolecular disulfide bond, wherein CNP is CNP-22, CNP -53 or a peptide comprising any amino acid sequence with 5 or more consecutive amino acids in the amino acid sequence CNP-22 or CNP-53 having a deletion (s), substitution (s) or addition (s) of any amino acid (s), and wherein the BNP is BNP-26, BNP-32, BNP-45 or a peptide comprising any amino acid sequence with 5 or more consecutive amino acids in the amino acid sequence of BNP-26, BNP-32 or BNP-45 having a deletion (deletions), substitution (s) or addition (s) of any amino acid (s), and where the hybrid peptide has CNP activity or BNP activity. 3. The therapeutic composition of claim 1, wherein said C-type natriuretic peptide (CNP) is CNP-22, CNP-53, or a CNP derivative in which1. Терапевтическая композиция, содержащая натрийуретический пептид С-типа (CNP) или натрийуретический пептид В-типа для (BNP) для лечениядерматита с иммунным ответом по крайней мере на один аллерген, выбранный из домашней пыли, клещей, кедровой пыльцы, пыльцы ежи сборной, пыльцы амброзии, яичного белка и яичного желтка,атопического дерматита,экземы,дерматита, который приводит к стероидному дерматиту,стероид-устойчивого дерматита,эритродермии,постэкзематозной эритродермии,розацеа илилюбого из перечислен
